[A retrospective historical study evaluating the safe use of current antidepressants in cardiology practice]

Area of Science:

• Cardiology
• Pharmacology
• Psychiatry

Background:

• Antidepressants are widely prescribed, but their cardiac safety in patients with pre-existing cardiovascular conditions requires thorough evaluation.
• Previous literature suggests potential cardiac risks associated with certain antidepressant classes.

Purpose of the Study:

• To confirm the cardiac safety profile of antidepressants in patients with cardiovascular disease.
• To evaluate electrocardiogram (ECG) QTc interval changes, blood pressure (BP), heart rate (HR), and hemorrhagic complications.

Main Methods:

• Retrospective analysis of 146 case histories, with a focus on 96 cardiac inpatients regularly taking antidepressants.
• Assessment of ECG QTc interval, BP (systolic and diastolic), HR, and hemorrhagic complications within 3-8 days of antidepressant initiation.

Main Results:

• No clinically significant changes in ECG QTc intervals were observed within 8 days of regular antidepressant use.
• No statistically significant differences in BP or HR dynamics were detected before and after 3-8 days of antidepressant administration.
• No hemorrhagic complications were reported in the study group receiving antidepressants.

Conclusions:

• New-generation antidepressants exhibit high cardiac safety during the initial week of therapy in cardiac patients.
• Lower daily dosages, often sufficient for cardiac patients with depression, contribute to minimizing adverse reactions.